University of Washington
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Washington sits in the top decile of US sponsors by registered trial count (#30 of 15,742 sponsors by registered trial count).
University of Washington: 1,048 sponsored US clinical trials, 156 recruiting.
University of Washington sponsors 1,048 registered US clinical trials on ClinicalTrials.gov, 156 of them currently recruiting, and 720 completed. 104 of these trials are in Phase 3-4 (later-stage) and 320 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 13 trials.
Top-decile sponsor footprint
University of Washington ranks in the top decile of sponsors by registered trial count (#30 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
720 of 816 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,048 total, page 11 of 21
Preventing HIV Among Native Americans Through the Treatment PTSD & Substance Use
NCT03112369
Volunteer-Delivery of Behavioral Activation
NCT03371771
Vitamin K Supplementation Study in Healthy Volunteers (Aim 2B)
NCT04450212
Genetic Testing for Men With Metastatic Prostate Cancer
NCT03503097
Effects of Retinoids on CYP2D6 Activity During Pregnancy
NCT03117660
RA-4: 13-cis Retinoic Acid for Treatment of Men With Azoospermia
NCT03323801
Early Ultrasound-guided Nerve Block for Painful Hand Injuries in the Emergency Department
NCT03195413
CT Perfusion Images in Assessing Treatment Response in Patients With Pancreatic Cancer
NCT03012282
Nivolumab and Plinabulin in Treating Patients With Stage IIIB-IV, Recurrent, or Metastatic Non-small Cell Lung Cancer
NCT02846792
Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer
NCT03050060
SynRinse Irrigation Pilot (SIP) Trial
NCT03154541
Mobile Motivational Physical Activity Targeted Intervention
NCT03160287
Pre-emptive Analgesics in Orthodontic Treatment
NCT03523988
Clearance of 25-hydroxyvitamin D in Cystic Fibrosis
NCT03104855
IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Undergoing Surgery
NCT03029611
Effect of Post-operative Ibuprofen After Surgery for Chronic Rhinosinusitis
NCT03055507
Personalized Health Assessment Related to Medications (Project PHARM)
NCT03037476
Factors Affecting the Speed of Recovery After ACL Reconstruction
NCT03770806
Experimental Test of Facebook Social Drinking Norms on Adolescent Alcohol Use
NCT03159286
Treatment Navigation for Opioid Use Disorder
NCT03398265
Pembrolizumab and Carboplatin in Treating Patients With Relapsed or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT03029598
A Phase II Neoadjuvant Study of Apalutamide, Abiraterone Acetate, Prednisone, Degarelix and Indomethacin in Men With Localized Prostate Cancer Pre-prostatectomy
NCT02849990
Sleep Intervention for Kids and Parents: A Self-Management Pilot Study
NCT03144531
Clearance of 25-hydroxyvitamin D in Chronic Kidney Disease
NCT02937350
Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
NCT03023046
American Indian and Alaska Native Men Who Have Sex With Men HIV & Substance Abuse Research
NCT03049904
Brief Online Training (BOLT) for Routine Outcome Monitoring
NCT05041517
Evaluating Technology-Based Fall Prevention Interventions
NCT03190460
Regional and Seasonal Variations in the Incidence and Causative Organisms for Post-traumatic Wound Infections and Osteomyelitis After Open Fractures
NCT03064009
Union Rate of Transverse Tibia Fracture
NCT03042533
Calcium Sulfate Spacer in Open Tibia Fractures
NCT03042546
Brief Alcohol Screening for Community College Students (BASICCS)
NCT04052386
Pembrolizumab in Treating Minimal Residual Disease in Patients With Acute Lymphoblastic Leukemia
NCT02767934
Individualized Response to Vitamin D Treatment Study
NCT02925195
Maternal Employment in Low and Middle-income Countries and Infant Feeding
NCT03209999
Web-Based Treatment of Heavy Drinking Among Women With a History of Sexual Trauma
NCT03111056
Effects of a Exercise Program on Health Outcomes in People With Diabetic Foot Ulcers
NCT03002155
Spontaneous Fetal EEG Recording During Labor
NCT03013569
Emotion Regulation Interventions for Alcohol-Related Sexual Aggression
NCT03159468
Higher or Lower Dose Cladribine, Cytarabine, and Mitoxantrone in Treating Medically Less Fit Patients With Newly Diagnosed Acute Myeloid Leukemia or Myeloid Neoplasm
NCT03012672
Sulfur Colloid SPECT/CT in Measuring Liver Function in Patients With Primary or Metastatic Liver Cancer Undergoing Radiation Therapy or Surgery
NCT02881554
Filgrastim, Cladribine, Cytarabine, and Mitoxantrone With Sorafenib in Treating Patients With Newly-Diagnosed, Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
NCT02728050
Phase 1 Clinical Trial of Sodium Nitrite for Out of Hospital Cardiac Arrest
NCT02987088
Bioimpedance as a Diagnostic Tool for Assessing the Need for Socket Modification in Transtibial Amputees
NCT03164356
Paclitaxel and Nortriptyline Hydrochloride in Treating Patients With Relapsed Small Cell Carcinoma
NCT02881125
Supplemental Enteral Protein in Critical Illness
NCT03170401
Study to Promote Innovation in Rural Integrated Telepsychiatry
NCT02738944
Mexiletine in Sporadic Amyotrophic Lateral Sclerosis
NCT02781454
Early Allogeneic Hematopoietic Cell Transplantation in Treating Patients With Relapsed or Refractory High-Grade Myeloid Neoplasms
NCT02756572
Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in Remission
NCT02780401
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 127 |
| Phase 2 | 193 |
| Phase 3 | 39 |
| Phase 4 | 65 |
What is open in the University of Washington pipeline
156 recruiting of 1,048 indexed (15% open); 720 completed (69%).
Phase mix: 104 late (III/IV) vs 320 early (I/II) (early-phase heavy).
Top condition: Depression (13 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Washington: open-pipeline peers nationwide
Peers matched on 1,048 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Washington sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,048 trials (± recruiting share)
- University of Wisconsin, Madison · 1,039 trials · 15% recruiting
- Bristol-Myers Squibb · 1,025 trials · 7% recruiting
- University of Florida · 1,106 trials · 15% recruiting
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Dompé Farmaceutici S.p.A · 15% recruiting · 27 trials
- Vanderbilt-Ingram Cancer Center · 15% recruiting · 189 trials
- Arizona State University · 15% recruiting · 187 trials
- Georgetown University · 15% recruiting · 227 trials
Related
What to do with this University of Washington page
1,048 registered trials is a research-attention snapshot, not an endorsement of University of Washington or any single study.
- 156 of University of Washington's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of Washington studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Washington pipeline card: 1,048 registered trials from official public datasets.Report a data error.